Social interactions in the Burkholderia cepacia complex: Biofilms and quorum sensing

Future Microbiology

Volumn 5, Issue 7, 2010, Pages 1087-1099

  Coenye, Tom ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

antimicrobial resistance; biofilm; Burkholderia cepacia; complex; quorum sensing

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DISINFECTANT AGENT; MEROPENEM; MINOCYCLINE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL GENOME; BIOFILM; BURKHOLDERIA CEPACIA COMPLEX; EPITHELIUM CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QUORUM SENSING; REVIEW; BIOLOGICAL MODEL; BURKHOLDERIA INFECTION; COMPLICATION; CYSTIC FIBROSIS; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; VIRULENCE;

BURKHOLDERIA CEPACIA; BURKHOLDERIA CEPACIA COMPLEX;

BIOFILMS; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MODELS, BIOLOGICAL; QUORUM SENSING; VIRULENCE;

EID: 77954742115     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.68     Document Type: Review

References (118)

1. Coenye T, Vandamme P: Diversity and significance of Burkholderia species occupying diverse ecological niches. Env. Microbiol. 5(9), 719-729 (2003).
2. Storms V, Van Den Vreken N, Coenye T et al.: Polyphasic characterisation of Burkholderia cepacia-like isolates leading to the emended description of Burkholderia pyrrocinia. Syst. Appl. Microbiol. 27(5), 517-526 (2004).
3. Vanlaere E, LiPuma JJ, Baldwin A et al.: Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. Int. J. Syst. Evol. Microbiol. 58(7), 1580-1589 (2008).
4. Vanlaere E, Baldwin A, Gevers D et al.: Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int. J. Syst. Evol. Microbiol. 59(1), 102-111 (2009).
5. Mahenthiralingam E, Vandamme P: Taxonomy and pathogenesis of the Burkholderia cepacia complex. Chron. Respir. Dis. 2(4), 209-217 (2005). (Pubitemid 41527263)
6. Mahenthiralingam E, Baldwin A, Dowson CG: Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology. J. Appl. Microbiol. 104(6), 1539-1551 (2008).
7. Mahenthiralingam E, Urban TA, Goldberg JB: The multifarious, multireplicon Burkholderia cepacia complex. Nat. Rev. Microbiol. 3(2), 144-156 (2005). (Pubitemid 40207595)
8. Conway BA, Venu V, Speert DP: Biofilm formation and acyl homoserine lactone production in the Burkholderia cepacia complex. J. Bacteriol. 184(20), 5678-5685 (2002).
9. Schwab U, Leigh M, Ribero C et al.: Patterns of epithelial cell invasion by different species of the Burkholderia cepacia complex in well-differentiated human airway epithelia. Infect. Immun. 70(8), 4547-4555 (2002).
10. Cunha MV, Sousa SA, Leitão JH, Moreira LM, Videira PA, Sá-Correia I: Studies on the involvement of the exopolysaccharides produced by cystic fibrosis associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections. J. Clin. Microbiol. 42(7), 3052-3058 (2004).
11. Tomlin KL, Clark SRD, Ceri H: Green and red fluorescent protein vectors for use in biofilm studies of the intrinsically resistant Burkholderia cepacia complex. J. Microbiol. Meth. 57(1), 95-106 (2004).
12. Savoia D, Zucca M: Clinical and environmental Burkholderia strains: biofilm production and intracellular survival. Curr. Microbiol. 54(6), 440-444 (2007).
13. Caraher E, Duff C, Mullen T et al.: Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans. J. Cyst. Fibros. 6(1), 49-56 (2007).
14. Brackman G, Hillaert U, Van Calenbergh S, Nelis HJ, Coenye T: Use of quorum sensing inhibitors to interfere with biofilm formation and development in Burkholderia multivorans and Burkholderia cenocepacia. Res. Microbiol. 160(2), 144-151 (2009).
15. Riedel K, Hentzer M, Geisenberger O et al.: N-acylhomoserine-lactone- mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed species biofilms. Microbiology 147(12), 3249-3262 (2001). (Pubitemid 33150331)
16. Riedel K, Eberl L: Social behaviour of members of the genus Burkholderia: quorum sensing and biofilms. In: Burkholderia: Molecular Microbiology and Genomics. Coenye T, Vandamme P (Eds), Horizon Bioscience, Wymondham, UK, 251-282 (2007).
17. Huber B, Riedel K, Hentzer M et al.: The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. Microbiology 147(9), 2517-2528 (2001). (Pubitemid 32899247)
18. Huber B, Riedel K, Köthe M, Givskov M, Molin S, Eberl L: Genetic analysis of functions involved in the late stages of biofilm development in Burkholderia cepacia H111. Mol. Microbiol. 46(2), 411-426 (2002).
19. Saldias MS, Lamothe J, Wu R, Valvano MA: Burkholderia cenocepacia requires the RpoN sigma factor for biofilm formation and intracellular trafficking within macrophages. Infect. Immun. 76(3), 1059-1067 (2008).
20. Aubert DF, Flannagan RS, Valvano MA: A novel sensor kinase response regulator hybrid controls biofilm formation and type VI secretion system activity in Burkholderia cenocepacia. Infect. Immun. 76(5), 1979-1991 (2008).
21. Watnick P, Kolter R: Biofilm, city of microbes. J. Bacteriol. 182(10), 2675-2679 (2000).
22. Goldstein R, Sun L, Jiang RZ, Sajjan U, Forstner JF, Campanelli C: Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J. Bacteriol. 177(4), 1039-1052 (1995).
23. Sajjan U, Liu L, Lu A, Spilker T, Forstner J, LiPuma JJ: Lack of cable pili expression by cblA-containing Burkholderia cepacia complex. Microbiology 148(11), 3477-3484 (2002).
24. Ryder C, Byrd M, Wozniak DJ: Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr. Opin. Microbiol. 10(6), 644-648 (2007).
25. Herasimenka Y, Cescutti P, Impallomeni G et al.: Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex. J. Cyst. Fibrosis. 6(2), 145-152 (2007).
26. Cérantola S, Lemassu-Jacquier A, Montrozier H: Structural elucidation of a novel exopolysaccharide produced by a mucoid clinical isolate of Burkholderia cepacia. Eur. J. Biochem. 260(2), 373-383 (1999).
27. Cérantola S, Bounéry JD, Segonds C, Marty N, Montrozier H: Exopolysaccharide production by mucoid and non-mucoid strains of Burkholderia cepacia. FEMS Microbiol. Lett. 185(2), 243-246 (2000).
28. Lagatolla C, Skerlavaj S, Dolzani L et al.: Microbiological characterisation of Burkholderia cepacia isolates from cystic fibrosis patients: investigation of the exopolysaccharides produced. FEMS Microbiol. Lett. 209(1), 99-106 (2002).
29. Chiarini L, Cescutti P, Drigo L et al.: Exopolysaccharides produced by Burkholderia cenocepacia recA lineages IIIA and IIIB. J. Cyst. Fibr. 3(3), 165-172 (2004).
30. Cescutti P, Bosco M, Picotti F et al.: Structural study of the exopolysaccharides produced by a clinical isolate of Burkholderia cepacia. Biochem. Biophys. Res. Commun. 273(3), 1088-1094 (2000).
31. Moreira LM, Videira PA, Sousa SA, Leitão JH, Cunha MV, Sa-Correia I: Identification and physical organization of the gene cluster involved in the biosynthesis of Burkholderia cepacia complex exopolysaccharides. Biochem. Biophys. Res. Commun. 312(2), 323-333 (2003).
32. Holden MT, Seth-Smith HM, Crossman LC et al.: The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J. Bacteriol. 191(1), 261-277 (2009).
33. Bartholdson SJ, Brown AR, Mewburn BR et al.: Plant host and sugar alcohol induced exopolysaccharides biosynthesis in the Burkholderia cepacia complex. Microbiology 154(8), 2513-2521 (2008).
34. Conway BA, Chu KK, Bylund J, Altman E, Speert DP: Production of exopolysaccharides by Burkholderia cenocepacia results in altered cell-surface interactions and altered bacterial clearance in mice. J. Infect. Dis. 190(5), 957-966 (2004).
35. Ferreira AS, Leitao JH, Silva IN et al.: Distribution of cepacian biosynthesis genes among environmental and clinical Burkholderia strains and role of cepacian exopolysaccharide in resistance to stress conditions. Appl. Env. Microbiol. 76(2), 441-450 (2010).
36. Pier GB, Coleman F, Grout M, Franklin M, Ohman DE: Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis. Infect. Immun. 69(3), 1895-1901 (2001). (Pubitemid 32187652)
37. Bylund J, Burgess LA, Cescutti P, Ernst RK, Speert DP: Exopolysaccharides from Burkholderia cenocepacia inhibit neutrophil chemotaxis and scavenge reactive oxygen species. J. Biol. Chem. 281(5), 2526-2532 (2006).
38. Chung JW, Altman E, Beveridge TJ, Speert DP: Colonial morphology of Burkholderia cepacia complex genomovar III: implication in exopolysaccharides production, pilus expression and persistence in mouse. Infect. Immun. 71(2), 904-909 (2003).
39. Lyczak JB, Cannon CL, Pier GB: Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15(2) 194-222 (2002).
40. Zlosnik JE, Hird TJ, Fraenkel MC, Moreira LM, Henry DA, Speert DP: Diferential mucoid exopolysaccharides production by members of the Burkholderia cepacia complex. J. Clin. Microbiol. 46(4), 1470-1473 (2008).
41. Burns JL: Antibiotic resistance of Burkholderia spp. In: Burkholderia: Molecular Microbiology and Genomics. Coenye T, Vandamme P (Eds). Horizon Bioscience, Wymondham, UK, 81-91 (2007).
42. Aronoff SC: Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a b-lactam-resistant mutant and in resistant cystic fibrosis isolates. Antimicrob. Agents. Chemother. 32(11), 1636-1639 (1988).
43. Burns JL, Clark DK: Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein. Antimicrob. Agents Chemother. 36(10), 2280-2285 (1992).
44. Guglierame P, Pasca MR, De Rossi E et al.: Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome. BMC Microbiol. 6, 66 (2006).
45. Buroni S, Pasca MR, Flannagan RS et al.: Assessment of three resistance-nodulation-cell division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance. BMC Microbiol. 9, 200 (2009).
46. Nair BM, Cheung KJ, Griffith A, Burns JL: Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J. Clin. Invest. 113(3), 464-473 (2004).
47. Burns JL, Lien DM, Hedin LA: Isolation and characterization of dihydrofolate-reductase from trimethoprim-susceptible and trimethoprim-resistant Pseudomonas cepacia. Antimicrob. Agents Chemother. 33(8), 1247-1251 (1989).
48. Nzula S, Vandamme P, Govan JRW: Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex. J. Antimicrob. Chemother. 50(2), 265-269 (2002).
49. Vermis K, Vandamme PAR, Nelis HJ: Burkholderia cepacia complex genomovars: utilization of carbon sources, susceptibility to antimicrobial agents and growth on selective media. J. Appl. Microbiol. 95(6), 1191-1199 (2003).
50. Mah TF, O'Toole GA: Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9(1), 34-39 (2001).
51. Donlan RM, Costerton JW: Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15(2), 167-193 (2002).
52. Stewart PS, Costerton JW: Antibiotic resistance of bacteria in biofilms. Lancet 358(9276), 135-138 (2001).
53. Jefferson KK, Goldmann DA, Pier GB: Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob. Agents Chemother. 49(6), 2467-2473 (2005).
54. McNee SG, Geddes DA, Weetman DA: Diffusion of sugars and acids in human dental plaque in vitro. Arch. Oral Biol. 27(11), 975-979 (1982).
55. Stewart PS: Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob. Agents Chemother. 40(11), 2517-2522 (1996).
56. Stewart PS: Diffusion in biofilms. J. Bacteriol. 185(5), 1485-1491 (2003).
57. Gordon CA, Hodges NA, Marriot C: Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic-fibrosis-derived Pseudomonas aeruginosa. J. Antimicrob. Chemother. 22(5), 667-674 (1988).
58. Nichols WW, Evans MJ, Slack MP, Walmsley HL: The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa. J. Gen. Microbiol. 135(5), 1291-1303 (1989).
59. Gordon CA, Hodges NA, Marriot C: Use of slime dispersants to promote antibiotic penetration through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 35(6), 1258-1260 (1991).
60. Dibdin GH, Assinder SJ, Nichols WW, Lambert PA: Mathematical model of b-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released b-lactamases. J. Antimicrob. Chemother. 38(5), 757-769 (1996).
61. Bagge N, Schuster M, Hentzer M et al.: Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and b-lactamase and alginate production. Antimicrob. Agents Chemother. 48(4), 1175-1187 (2004).
62. Stewart PS, Franklin MJ: Physiological heterogeneity in biofilms. Nat. Rev. Microbiol. 6(3), 199-210 (2008).
63. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K: Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230(1), 13-18 (2004).
64. Lewis K: Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45(4), 999-1007 (2001).
65. Lewis K: Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5(1), 48-56 (2007).
66. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K: Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186(24), 8172-8180 (2004).
67. Brooun A, Liu S, Lewis K: A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 44(3), 640-646 (2000).
68. Harrison JJ, Turner RJ, Ceri H: Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa. Environ. Microbiol. 7(7), 981-994 (2005).
69. LaFleur MD, Kumamoto CA, Lewis K: Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob. Agents Chemother. 50(11), 3839-3846 (2006).
70. Spoering A, Lewis K: Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183(23), 6746-6751 (2001).
71. Al-Dhaheri RS, Douglas LJ: Absence of amphotericin B-tolerant persister cells in biofilms of some Candida species. Antimicrob. Agents Chemother. 52(5), 1884-1887 (2008).
72. Singh R, Ray P, Das A, Sharma M: Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. J. Med. Microbiol. 58(8), 1067-1073 (2009).
73. Möker N, Dean CR, Tao J: Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J. Bacteriol. 192(7), 1946-1955 (2010).
74. Caraher E, Reynolds G, Murphy P, McClean S, Callaghan M: Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro. Eur. J. Clin. Microbiol. Infect. Dis. 26(3), 213-216 (2007).
75. Peeters E, Nelis HJ, Coenye T: In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/ sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria. J. Antimicrob. Chemother. 64(4), 801-809 (2009).
76. Desai M, Bühler T, Weller PH, Brown MR: Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth. J. Antimicrob. Chemother. 42(2), 153-160 (1998).
77. Dales L, Ferris W, Vandemheen K, Aaron SD: Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis. Eur. J. Clin. Microbiol. Infect. Dis. 28(10), 1275-1279 (1994).
78. Peeters E, Nelis HJ, Coenye T: Evaluation of the efficacy of disinfection procedures against Burkholderia cenocepacia biofilms. J. Hosp. Infect. 70(4), 361-368 (2008).
79. MacDonald KJ, Speert DP: Interaction of Burkholderia species with the phagocytic system. In: Burkholderia: Molecular Microbiology and Genomics. Coenye T, Vandamme P (Eds). Horizon Bioscience, Wymondham, UK, 111-127 (2007).
80. LiPuma JJ, Rathinavelu S, Foster BK et al.: In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species. Antimicrob. Agents Chemother. 53(1), 249-255 (2009).
81. Banin E, Vasil ML, Greenberg EP: Iron and Pseudomonas aeruginosa biofilm formation. Proc. Natl Acad. Sci. USA 102(31), 11076-11081 (2005).
82. Caraher EM, Gumulapurapu K, Taggart CC, Murphy P, McClean S, Callaghan M: The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms. J. Antimicrob. Chemother. 60(3), 546-554 (2007).
83. Kaneko Y, Thoendel M, Olakanmi O, Britigan BE, Singh PK: The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J. Clin. Invest. 117(4), 877-888 (2007).
84. Peeters E, Nelis HJ, Coenye T: Resistance of planktonic and biofilm-grown Burkholderia cepacia complex isolates to the transition metal gallium. J. Antimicrob. Chemother. 61(5), 1062-1065 (2008).
85. Peeters E, Sass A, Mahenthiralingam E, Nelis H, Coenye T: Transcriptional response of Burkholderia cenocepacia J2315 sessile cells to treatments with high doses of hydrogen peroxide and sodium hypochlorite. BMC Genomics 11(1), 90 (2010).
86. Panmanee W, Hassett DJ: Differential role of OxyR-controlled antioxidant enzymes alkyl hydroperoxide reductase (AhpCF) and catalase (KatB) in the protection of Pseudomonas aeruginosa against hydrogen peroxide in biofilm vs. planktonic culture. FEMS Microbiol. Lett. 295(2), 238-244 (2009).
87. Sass AM, Marchbank A, Drevinek P, Mahenthiralingam E. Changes in gene expression of B. cenocepacia J2315 in respons to different classes of antibiotics. Presented at: 13th Meeting of the International Burkholderia cepacia Working Group. Toronto, ON, Canada, 23-26 April 2009.
88. Huber B, Feldmann F, Köthe M et al.: Identification of a novel virulence factor in Burkholderia cenocepacia H111 required for efficient slow killing of Caenorhabditis elegans. Infect. Immun. 72(12), 7220-7230 (2004).
89. Weingart CL, White CE, Liu S et al.: Direct binding of the quorum sensing regulator CepR of Burkholderia cenocepacia to two target promoters in vitro. Mol. Microbiol. 57(2), 452-467 (2005).
90. O'Grady EP, Viteri DF, Malott RJ, Sokol PA: Reciprocal regulation by the CepIR and CciIR quorum sensing systems in Burkholderia cenocepacia. BMC Genomics 10, 441 (2009).
91. Uehlinger S, Schwager S, Bernier SP et al.: Identification of specific and universal virulence factors in Burkholderia cenocepacia strains using multiple infection hosts. Infect. Immun. 77(9), 4102-4110 (2009).
92. Bassler BL, Wright M, Showalter RE, Silverman MR: Intercellular signalling in Vibrio harveyi: sequence and function of genes regulating expression of luminescence. Mol. Microbiol. 9(4), 773-786 (1993).
93. Bassler BL, Wright M, Silverman MR: Multiple signalling systems controlling expression of luminescence in Vibrio harveyi: sequence and function of genes encoding a second sensory pathway. Mol. Microbiol. 13(2), 273-286 (1994).
94. Gotschlich A, Huber B, Geisenberger O et al.: Synthesis of multiple N-acylhomoserine lactones is wide-spread among the members of the Burkholderia cepacia complex. Syst. Appl. Microbiol. 24(1), 1-14 (2001).
95. Lutter E, Lewenza S, Dennis JJ, Visser MB, Sokol PA: Distribution of quorum-sensing genes in the Burkholderia cepacia complex. Infect. Immun. 69(7), 4661-4666 (2001).
96. Malott RJ, O'Grady EP, Toller J, Inhülsen S, Eberl L, Sokol PA: A Burkholderia cenocepacia orphan LuxR homolog is involved in quorum-sensing regulation. J. Bacteriol. 191(8), 2447-2460 (2009).
97. Aguilar C, Bertani I, Venturi V: Quorum-sensing system and stationary phase sigma factor (rpoS) of the onion pathogen Burkholderia cepacia genomovar I type strain, ATCC25416. Appl. Env. Microbiol. 69(3), 1739-1747 (2003).
98. Subsin B, Chambers CE, Visser MB, Sokol PA: Identification of genes regulated by the cepIR quorum-sensing system in Burkholderia cenocepacia by high-throughput screening of a random promoter library. J. Bacteriol. 189(3), 968-979 (2007).
99. Riedel K, Arevalo-Ferro C, Reil G, Gorg A, Lottspeich F, Eberl L: Analysis of the quorum-sensing regulon of the opportunistic pathogen Burkholderia cepacia H111 by proteomics. Electrophoresis 24(4), 740-750 (2003).
100. Chambers CE, Lutetr EI, Visser MB, Law PP, Sokol PA: Identification of potential CepR regulated genes using a cep box motif-based search of the Burkholderia cenocepacia genome. BMC Microbiol. 6, 104 (2006).
101. Venturi V, Friscina A, Bertani I, Devescovi G, Aguilar C: Quorum sensing in the Burkholderia cepacia complex. Res. Microbiol. 155(4), 238-244 (2004).
102. Dubern JF, Diggle SP: Quorum sensing by 2-alkyl-4-quinolones in Pseudomonas aeruginosa and other bacterial species. Mol. Biosyst. 4(9), 882-888 (2008).
103. Boon C, Deng Y, Wang LH et al.: A novel DSF-like signal from Burkholderia cenocepacia interferes with Candida albicans morphological transition. ISME J. 2(1), 27-36 (2008).
104. Diggle SP, Lumjiaktase P, Dipilato F et al.: Functional genetic analysis reveals a 2-alkyl-4-quinolone signaling system in the human pathogen Burkholderia pseudomallei and related bacteria. Chem. Biol. 13(7), 701-710 (2006).
105. Vial L, Lépine F, Milot S et al.: Burkholderia pseudomallei, B. thailandensis, and B. ambifaria produce 4-hydroxy-2- alkylquinoline analogues with a methyl group at the 3 position that is required for quorum-sensing regulation. J. Bacteriol. 190(15), 5339-5352 (2008).
106. Deng Y, Boon C, Eberl L, Zhang LH: Differential modulation of Burkholderia cenocepacia virulence and energy metabolism by the quorum-sensing signal BDSF and its synthase. J. Bacteriol. 191(23), 7270-7278 (2009).
107. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP: The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280(5361), 295-298 (1998).
108. Heydorn A, Ersbøll B, Kato J et al.: Statistical analysis of Pseudomonas aeruginosa biofilm development: impact of mutations in genes involved in twitching motility, cell-to-cell signaling, and stationary-phase sigma factor expression. Appl. Env. Microbiol. 68(4), 2008-2017 (2002).
109. Purevdorj B, Costerton JW, Stoodley P: Influence of hydrodynamics and cell signaling on the structure and behavior of Pseudomonas aeruginosa biofilms. Appl. Env. Microbiol. 68(9), 4457-4464 (2002).
110. Hentzer M, Riedel K, Rasmussen TB et al.: Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 148(1), 87-102 (2002).
111. Bjarnsholt T, Jensen PØ, Burmølle M et al.: Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 151(2), 373-383 (2005).
112. Tomlin KL, Malott RJ, Ramage G, Storey DG, Sokol PA, Ceri H: Quorum-sensing mutations affect attachment and stability of Burkholderia cenocepacia biofilms. Appl. Env. Microbiol. 71(9), 5208-5218 (2005).
113. Wopperer J, Cardona ST, Huber B, Jacobi CA, Valvano MA, Eberl L: A quorum-quenching approach to investigate the conservation of quorum-sensing-regulated functions within the Burkholderia cepacia complex. Appl. Env. Microbiol. 72(2), 1579-1587 (2006).
114. Eberl L: Quorum sensing in the genus Burkholderia. Int. J. Med. Microbiol. 296(2-3), 103-110 (2006).
115. Sokol PA, Malott RJ, Riedel K, Eberl L: Communication systems in the genus Burkholderia: global regulators and targets for novel antipathogenic drugs. Future Microbiol. 2(5), 555-563 (2007).
116. Riedel K, Köthe M, Kramer B et al.: Computer-aided design of agents that inhibit the cep quorum-sensing system of Burkholderia cenocepacia. Antimicrob. Agents Chemother. 50(1), 318-323 (2006).
117. Tomlin KL, Coll OP, Ceri H: Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia. Can. J. Microbiol. 47(10), 949-954 (2001). Website
118. The MEME Suite - Motif-based sequence analysis tools http://meme.sdsc. edu/